Thrombolytic Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
Conditions: Cerebral Infarction; Brain Ischemia; StrokeIntervention: Drug: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)Sponsor: University of AlbertaRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2014 Category: Research Source Type: clinical trials
